Table 3.
AD biomarker | Variables | Presence of any detectable stenosis | |||||||
Any extracranial carotid stenosis | Any intracranial stenosis | ||||||||
Stenosis− | Stenosis+ | p value | da | Stenosis− | Stenosis+ | p value | d | ||
Aβ biomarker | Global Aβ | 1.185 ± 0.245 | 1.173 ± 0.160 | 0.810 | 0.052 | 1.182 ± 0.243 | 1.190 ± 0.230 | 0.782 | − 0.037 |
Neurodegeneration biomarker | AD-CT | 2.877 ± 0.170 | 2.743 ± 0.173 | < 0.001* | 0.786 | 2.890 ± 0.171 | 2.804 ± 0.165 | < 0.001* | 0.505 |
HVa | − 732 ± 810 | − 1067 ± 1076 | 0.066 | 0.401 | − 686 ± 832 | − 953 ± 0827 | 0.017* | 0.322 | |
Presence of stenosis based on severity threshold | |||||||||
≥ 50% intracranial stenosisb | Number of stenotic intracranial arteries ≥ 2c | ||||||||
Stenosis− | Stenosis+ | p value | d | Stenosis− | Stenosis+ | p value | d | ||
Aβ biomarker | Global Aβ | 1.179 ± 0.234 | 1.258 ± 0.293 | 0.165 | − 0.331 | 1.189 ± 0.242 | 1.157 ± 0.221 | 0.409 | 0.136 |
Neurodegeneration biomarker | AD-CT | 2.871 ± 0.175 | 2.801 ± 0.136 | 0.091 | 0.403 | 2.882 ± 0.169 | 2.780 ± 0.178 | < 0.001* | 0.603 |
HVa | − 746 ± 838 | − 937 ± 837 | 0.338 | 0.228 | − 726 ± 840 | − 938 ± 810 | 0.123 | 0.254 | |
Presence of stenosis according to location | |||||||||
Anterior circulation | Posterior circulation | ||||||||
Stenosis− | Stenosis+ | p value | d | Stenosis− | Stenosis+ | p value | d | ||
Aβ biomarker | Global Aβ | 1.187 ± 0.245 | 1.175 ± 0.220 | 0.711 | 0.052 | 1.185 ± 0.241 | 1.175 ± 0.212 | 0.854 | 0.042 |
Neurodegeneration biomarker | AD-CT | 2.884 ± 0.172 | 2.811 ± 0.167 | 0.002* | 0.428 | 2.876 ± 0.170 | 2.744 ± 0.181 | 0.001* | 0.772 |
HVa | − 710 ± 837 | − 911 ± 828 | 0.082 | 0.242 | − 760 ± 836 | − 746 ± 875 | 0.943 | − 0.016 |
Data for continuous variables presented as means ± SD (SUVR for global Aβ, mm for AD-CT, and mm3 for HVa)
CN cognitively normal, SUVR standardized uptake value ratio, AD-CT Alzheimer’s disease-signature cortical thickness, HVa hippocampal volume adjusted for intracranial volume
ad indicates Cohen’s delta
b“Stenosis−” group of “≥ 50% intracranial stenosis” means individuals with no stenosis or < 50% intracranial stenosis
c“Stenosis−” group of “number of stenotic intracranial arteries ≥ 2” means patients with no stenosis or only one stenotic intracranial artery
*p < 0.05